Health 21 hours ago New Ozempic-alternative diabetes pill burns fat without muscle loss, study suggests Researchers have created an oral medication that could work alone or with GLP-1 drugs to improve metabolic health while preserving muscle mass in diabetes patients.
Health 1 day ago Breakthrough GLP-1 implant promises major weight-loss benefits for pets The world's first GLP-1 weight-loss treatment for pets has begun with successful cat dosing. The six-month implant could revolutionize obesity care for cats, experts say.
Health 5 days ago Alzheimer's risk could rise with common condition affecting millions, study finds A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong connection between weight and brain disease progression.
VIDEO December 3 Study: Underage social media users at higher risk of depression, obesity Social media reform advocate Nicki Petrossi joins 'America's Newsroom' to discuss a study finding increased social media use among children and teens can lead to a higher risk of depression, obesity, sleep deprivation and more.
Health December 2 Weight-loss drugs could become unavailable for millions in coming years The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion people globally and is expected to double by 2030.
Health December 1 Men with 'beer bellies' may face serious heart damage regardless of weight New study reveals "beer bellies" increase heart damage risk even in people with normal weight, challenging traditional views on cardiovascular health.
Health November 30 America's most popular cooking oil may be linked to obesity, new study finds New research links America's most popular cooking oil to obesity through metabolic pathways that convert fatty acids into weight-promoting compounds.
Health November 30 Doctor warns of 2 simple food mistakes that increase chronic disease risk A doctor based in Colorado reveals how nutrition can prevent fatal diseases like cancer. Simple dietary changes may ward off obesity, diabetes and autoimmune conditions.
Health November 26 On a GLP-1? How to survive holiday meals without derailing your progress GLP-1 weight-loss drugs can make holiday family dinners challenging, as appetite changes affect social eating habits and relationships with food traditions.
Health November 24 New weight-loss shot shows major fat reduction, but experts urge caution The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond current GLP-1 medications.
Food-Drink November 22 Young adults may be especially prone to overeating ultra-processed foods, study finds A new study reveals young adults aged 18-21 are more vulnerable to ultra-processed foods, consuming nearly 100 extra calories daily when not hungry.
Health November 14 GLP-1 weight-loss medications linked to improved cancer survival in certain patients GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San Diego researchers found in a 6,800-patient study.
Travel November 11 Overweight foreigners seeking visas may be rejected to save healthcare costs, taxpayer expense U.S. embassies have received guidance to consider denying visas to overweight applicants and those with chronic health conditions, citing potential financial costs to American taxpayers.
Health November 10 Killer condition lands in top 10 leading causes of death as global cases surge Chronic kidney disease now ranks as the ninth leading cause of death globally, affecting 788 million people worldwide, according to major health study.
Health November 9 America’s fattest states revealed — and how Ozempic is changing the map Insurance data reveals dramatic regional differences in Ozempic and Mounjaro usage, with obesity-heavy states prescribing GLP-1 medications at triple the rate of others.
VIDEO November 6 Trump, RFK Jr. and Dr. Oz announce Medicare weight loss drug deal President Donald Trump, HHS Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz announce a deal for Americans taking weight loss drugs.
Health October 28 'Skinny fat’ warning issued as study finds hidden obesity behind normal BMI New research reveals that one in five people with normal BMIs have hidden abdominal obesity, facing 29% higher blood pressure risk and 81% higher diabetes odds despite appearing thin.
Health October 26 Popular weight-loss drugs could take the edge off your alcohol buzz, study finds GLP-1 medications such as Ozempic and Wegovy appear to make people feel less drunk and reduce alcohol cravings by delaying gastric emptying, researchers report.
Soft Drinks October 18 Scientists reveal how your favorite soda could quietly mess with your mood Women who regularly consume soft drinks face a 16% higher risk of major depression, according to new research examining gut bacteria and mental health connections.
Food-Drink October 16 Even low-calorie processed food causes weight gain, testosterone loss in men, study suggests Danish researchers suggest that food processing itself harms men's metabolic and reproductive health, prompting calls to revise nutritional guidelines.
Health October 10 Ozempic and similar drugs could interfere with common medical procedure, research warns A new study reveals that GLP-1 drugs may affect medical scan results, though experts say findings are preliminary and more data is needed before changing medical practice.
Health October 7 Experts sound alarm as weight-loss shortcut could put Americans at risk High costs and shortages are driving demand for unregulated GLP-1 drugs, prompting FDA alerts about counterfeit Ozempic and calls for stricter enforcement by legal experts.
Health October 2 Weight-loss surgery pros and cons in the spotlight after singer's 'scary' experience Weight-loss experts explain why combining GLP-1 medications with bariatric surgery may be the most effective approach to treating obesity in 2025.
Health September 29 Weight-loss drugs now linked to cancer protection in women, major new study reveals A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian cancers, in obese adults. Oncologist Dr. Slomovitz discusses the findings.
VIDEO September 28 Oncology director shares how GLP-1s can help protect against cancer Dr. Brian Slomovitz, director of gynecologic oncology at Mount Sinai Medical Center in Miami Beach, Florida, says the link between GLP-1 and reduced cancer risk is "not surprising."
Health September 25 Weight-loss doctor shares how GLP-1s could rewire body against disease New York City doctors reveals how weight-loss drugs reduce inflammatory cytokines by decreasing fat cells, potentially preventing cancer and autoimmune diseases.
VIDEO September 24 Weight loss drugs show promise in reducing inflammation beyond fat burning, doctor says Dr. Sue Decotiis, a New York City weight loss physician, discusses how GLP-1s impact inflammation, relieving conditions from arthritis to cancer.
Health September 23 No more injections? New pill could replace Ozempic and Wegovy for weight loss A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially providing an easier alternative to Ozempic injections.
Health September 21 Dan Marino’s metabolic liver disease highlights growing health concern Metabolic dysfunction-associated steatohepatitis (MASH) is a silent liver disease that is caused by fat buildup, inflammation and cell damage in the liver. Here's what to know.
Health September 20 Researchers say being 'fat but fit' could be less deadly than being underweight New research challenges BMI assumptions, showing overweight individuals may not face higher death rates while underweight people show increased mortality risk.
